These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23638739)

  • 1. New research in HIV immunity points way for vaccine.
    Rees J
    Immunotherapy; 2013 May; 5(5):445-6. PubMed ID: 23638739
    [No Abstract]   [Full Text] [Related]  

  • 2. New research in HIV immunity points way for vaccine.
    Rees J
    Expert Rev Clin Immunol; 2013 May; 9(5):403. PubMed ID: 23772447
    [No Abstract]   [Full Text] [Related]  

  • 3. Measuring HIV-1-specific T cell immunity: how valid are current assays?
    D'Souza MP; Altfeld M
    J Infect Dis; 2008 Feb; 197(3):337-9. PubMed ID: 18184092
    [No Abstract]   [Full Text] [Related]  

  • 4. T cells versus HIV-1: fighting exhaustion as well as escape.
    Robinson HL
    Nat Immunol; 2003 Jan; 4(1):12-3. PubMed ID: 12496971
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterization of functional and phenotypic changes in anti-Gag vaccine-induced T cell responses and their role in protection after HIV-1 infection.
    Betts MR; Exley B; Price DA; Bansal A; Camacho ZT; Teaberry V; West SM; Ambrozak DR; Tomaras G; Roederer M; Kilby JM; Tartaglia J; Belshe R; Gao F; Douek DC; Weinhold KJ; Koup RA; Goepfert P; Ferrari G
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4512-7. PubMed ID: 15753288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and safety of an HIV-1 lipopeptide vaccine in healthy adults: a phase 2 placebo-controlled ANRS trial.
    Salmon-Céron D; Durier C; Desaint C; Cuzin L; Surenaud M; Hamouda NB; Lelièvre JD; Bonnet B; Pialoux G; Poizot-Martin I; Aboulker JP; Lévy Y; Launay O;
    AIDS; 2010 Sep; 24(14):2211-23. PubMed ID: 20625264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoxic T lymphocyte response may predict HIV‑1 disease progression.
    Wilkinson J
    Immunotherapy; 2012 Nov; 4(11):1092-3. PubMed ID: 23326917
    [No Abstract]   [Full Text] [Related]  

  • 8. Is an HIV vaccine possible?
    McMichael AJ; Hanke T
    Nat Med; 1999 Jun; 5(6):612-4. PubMed ID: 10371492
    [No Abstract]   [Full Text] [Related]  

  • 9. Modulation of HIV reservoirs by host HLA: bridging the gap between vaccine and cure.
    Brumme ZL; Chopera DR; Brockman MA
    Curr Opin Virol; 2012 Oct; 2(5):599-605. PubMed ID: 22939190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elucidating the elite: mechanisms of control in HIV-1 infection.
    O'Connell KA; Bailey JR; Blankson JN
    Trends Pharmacol Sci; 2009 Dec; 30(12):631-7. PubMed ID: 19837464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines for HIV--looking to the future.
    TreatmentUpdate; 2004 Oct; 16(6):1-3. PubMed ID: 17219677
    [No Abstract]   [Full Text] [Related]  

  • 12. Vaccine-induced CD8+ T lymphocytes of rhesus monkeys recognize variant forms of an HIV epitope but do not mediate optimal functional activity.
    Hulot SL; Cale EM; Korber BT; Letvin NL
    J Immunol; 2011 May; 186(10):5663-74. PubMed ID: 21490161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel CD8+ T cell-based vaccine stimulates Gp120-specific CTL responses leading to therapeutic and long-term immunity in transgenic HLA-A2 mice.
    Nanjundappa RH; Wang R; Xie Y; Umeshappa CS; Xiang J
    Vaccine; 2012 May; 30(24):3519-25. PubMed ID: 22484292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The STEP study provides a hint that vaccine induction of the right CD8+ T cell responses can facilitate immune control of HIV.
    Altfeld M; Goulder PJ
    J Infect Dis; 2011 Mar; 203(6):753-5. PubMed ID: 21343145
    [No Abstract]   [Full Text] [Related]  

  • 15. AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope.
    Emini EA; Koff WC
    Science; 2004 Jun; 304(5679):1913-4. PubMed ID: 15218131
    [No Abstract]   [Full Text] [Related]  

  • 16. [Vaccines against HIV].
    Holm-Hansen C
    Tidsskr Nor Laegeforen; 2006 Nov; 126(23):3117-20. PubMed ID: 17160118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Protective mucosal immunity and HIV-1 mucosal vaccine strategy].
    Huang Y; Huang XG; Xu JQ
    Bing Du Xue Bao; 2009 Jul; 25(4):318-22. PubMed ID: 19769168
    [No Abstract]   [Full Text] [Related]  

  • 18. HIV/AIDS vaccines: 2007.
    Robinson HL
    Clin Pharmacol Ther; 2007 Dec; 82(6):686-93. PubMed ID: 17971817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines and immunology: elucidating immunity to HIV-1 and current prospects for AIDS vaccine development.
    Heeney JL; Hahn BH
    AIDS; 2000; 14 Suppl 3():S125-7. PubMed ID: 11086855
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunogenicity assay validation for an HIV vaccine trial: high IFNγ+/IL-2+ CD8+ T cells background in healthy Thais.
    Sirivichayakul S; Thantiworasit P; Chatkulkawin P; Buranapraditkun S; Munier ML; Kelleher AD; Ruxrungtham K
    Vaccine; 2011 Aug; 29(35):6002-7. PubMed ID: 21718737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.